Privia Health Group, Inc (PRVA) insider trading
Every open-market stock purchase and sale by Privia Health Group, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $22.2M over the last 12 months (24 sales). No open-market buys.
- Last insider buy: Adam Boehler (Director), $6K, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $22.2M (24 sales). Last close $22.89 on Oct 22, 2026.
Recent PRVA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 1, 2026 | Opella Finley Ernest (Director) | Bought (not open market) | — |
| Jul 9, 2026 | David Mountcastle (CFO) | Sold | $589K |
| Jul 7, 2026 | David Mountcastle (CFO) | Sold | $16.5K |
| Jul 6, 2026 | Matthew Shawn Morris (Director) | Sold | $1.5M |
| Jul 6, 2026 | Matthew Shawn Morris (Director) | Bought (not open market) | — |
| Jul 2, 2026 | Matthew Shawn Morris (Director) | Sold | $1.6M |
| Jul 2, 2026 | David Mountcastle (CFO) | Sold | $680K |
| Jul 2, 2026 | Matthew Shawn Morris (Director) | Bought (not open market) | — |
| Jul 1, 2026 | Matthew Shawn Morris (Director) | Sold | $1.2M |
| Jul 1, 2026 | Matthew Shawn Morris (Director) | Sold | $998K |
| Jul 1, 2026 | Matthew Shawn Morris (Director) | Bought (not open market) | $165K |
| Jul 1, 2026 | Matthew Shawn Morris (Director) | Bought (not open market) | — |
| Jun 30, 2026 | Matthew Shawn Morris (Director) | Sold | $1.4M |
| Jun 30, 2026 | Matthew Shawn Morris (Director) | Bought (not open market) | $106K |
| Jun 30, 2026 | Matthew Shawn Morris (Director) | Bought (not open market) | — |
| Jun 29, 2026 | Matthew Shawn Morris (Director) | Sold | $1.6M |
| Jun 29, 2026 | Matthew Shawn Morris (Director) | Bought (not open market) | — |
| Jun 26, 2026 | Matthew Shawn Morris (Director) | Sold | $2.2M |
| Jun 26, 2026 | David Mountcastle (CFO) | Sold | $433K |
| Jun 26, 2026 | David Mountcastle (CFO) | Bought (not open market) | $34.4K |
| Jun 26, 2026 | David Mountcastle (CFO) | Bought (not open market) | — |
| Jun 26, 2026 | David Mountcastle (CFO) | Bought (not open market) | — |
| Jun 26, 2026 | David Mountcastle (CFO) | Bought (not open market) | — |
| Jun 26, 2026 | Matthew Shawn Morris (Director) | Bought (not open market) | — |
| Jun 26, 2026 | David Mountcastle (CFO) | Bought (not open market) | — |
Who's trading PRVA
- Opella Finley Ernest, Director: other filings, last Sep 1, 2026
- David Mountcastle, CFO: sold $3.7M (16 sales), last Jul 9, 2026
- Matthew Shawn Morris, Director: sold $11.9M (12 sales), last Jul 6, 2026
- Jaewon Ryu, Director: other filings, last May 20, 2026
- Francis S Soistman Jr, Director: other filings, last May 20, 2026
- Thomas A McCarthy, Director: other filings, last May 20, 2026
- Nancy G Cocozza, Director: other filings, last May 20, 2026
- David P King, Director: other filings, last May 20, 2026
- Pamela O Kimmet, Director: other filings, last May 20, 2026
- Lance Berberian, Director: other filings, last May 20, 2026
- Parth Mehrotra, CEO: sold $6.4M (10 sales), last May 12, 2026
- Edward C Fargis, VP: sold $215K (2 sales), last Mar 10, 2026
Get free alerts when an insider at Privia Health Group, Inc files a new trade →